CoChat

Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression

Open access

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Abstract

The transcription factor (TF) Ikaros zinc finger 1 (IKZF1) is essential for B-cell development, and recurrently mutated in human B-cell acute lymphoblastic leukemia (B-ALL). IKZF1 has been ascribed both activating and repressive functions via interactions with coactivator and corepressor complexes, but the relative abundance of IKZF1-associated coregulators and their contribution to IKZF1-mediated gene regulation are not well understood. To address this, we performed an unbiased identification of IKZF1-interacting proteins in pre-B cells and found that IKZF1 interacts overwhelmingly with corepressors and heterochromatin-associated proteins. Time-resolved analysis of transcription and chromatin state identified transcriptional repression as the immediate response to IKZF1 induction. Transcriptional repression preceded transcriptional activation by several hours, manifesting as a decrease in the fraction of transcriptional bursts at the single-molecule level. Repression was accompanied by a rapid loss of chromatin accessibility and reduced levels of histone H3 lysine 27 acetylation (H3K27ac), particularly at enhancers. We identified highly conserved helical motifs within the intrinsically disordered region of IKZF1 that mediate its association with the nucleosome remodeling and deacetylase (NuRD) corepressor complex through critical “KRK” residues that bind the NuRD subunit retinoblastoma binding protein 4 (RBBP4), a mechanism shared with the TFs FOG1, BCL11A, and SALL4. Functional characterization reveals that this region is necessary for the efficient silencing of target genes and antiproliferative functions of IKZF1 in B-ALL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2024024787

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 IKZF1 interactome is strongly biased for corepressors over coactivators A. IKZF1 ChIP-MS interacting proteins ranked by abundance (log10 iBAQ mean of three replicates), with IKZF1 in maroon, IKZF3 (Aiolos) in red, NuRD subunits in blue, KAP1 in yellow, FACT subunits in green, and SWI/SNF subunits in orange. B. Top 20% most abundant IKZF1 ChIP-MS interacting proteins, classified into chromatin coregulators, transcription factors, post-translational modification enzymes, and RNA-processing factors. C. iBAQ abundance of HDAC1/2 and RBBP4/7-containing complexes NuRD, SIN3, and CoREST, and the RBBP4/7-containing complex PRC2. Average and standard deviation of three replicates. D. Most abundant IKZF1 ChIP-MS corepressors versus coactivators. Average and standard deviation of three replicates.
Figure 1 IKZF1 interactome is strongly biased for corepressors over coactivators A. IKZF1 ChIP-MS interacting proteins ranked by abundance (log10 iBAQ mean of three replicates), with IKZF1 in maroon, IKZF3 (Aiolos) in red, NuRD subunits in blue, KAP1 in yellow, FACT subunits in green, and SWI/SNF subunits in orange. B. Top 20% most abundant IKZF1 ChIP-MS interacting proteins, classified into chromatin coregulators, transcription factors, post-translational modification enzymes, and RNA-processing factors. C. iBAQ abundance of HDAC1/2 and RBBP4/7-containing complexes NuRD, SIN3, and CoREST, and the RBBP4/7-containing complex PRC2. Average and standard deviation of three replicates. D. Most abundant IKZF1 ChIP-MS corepressors versus coactivators. Average and standard deviation of three replicates.CC BY · PubMed Central
Figure 2 IKZF1 induces rapid loss of chromatin accessibility and H3K27ac at selective sites across the genome A. Inducible IKZF1-ERt2 pre-B model, where 4-Hydroxytamoxifen (4-OHT) induces synchronous nuclear entry of IKZF1-ERt2. B. Heatmap of differentially expressed genes (padj <0.01 and log2FC>1 or <-1) over 24h nascent chromatin-associated RNA-seq timecourse following IKZF1 induction performed in duplicate, and K-means clusters of genes by behaviour into C1 Fast Repressed, C2 Slow Repressed, C3 Activated and C4 Slow Activated. C. Scaled normalized expression for K-means clusters C1 Fast Repressed, C2 Slow Repressed, C3 Activated, and C4 Slow Activated genes, with red line and grey area indicating mean and 95% confidence intervals respectively. The time for genes in each cluster to reach half-maximal repression or activation is indicated by t-half. D. Left – Total Nucleosome Free Region (NFR) ATAC peaks called by MACS2 from ATAC-seq performed in duplicate and proportion of ATAC peaks with significant differential accessibility within 2h of IKZF1 induction, decreased accessibility in blue (2h vs 0h padj<0.01, FC<0), and increased accessibility in yellow (2h vs 0h padj <0.01, FC>0). Right - Relative genomic distribution of ATAC NFR peaks at CTCF sites, Promoters, Intragenic, and Intergenic for sites with early decreased accessibility, early increased accessibility, and a subset of sites with unchanged accessibility (padj>0.05, log2FC[-0.2,0.2]), and all accessible sites. E. Homer motif analysis showing top enriched motifs at ATAC NFR regions with early decreased accessibility compared to regions with unchanged accessibility. F. Number of IKZF motif (GGAA and GGGA) at sites with early decreased accessibility, increased accessibility, or unchanged accessibility. G. IGV browser track of ATAC and IKZF1-ERt2 at 0h and 1h following IKZF1 induction at sites with early decreased accessibility (top panel) and sites with early increased or unchanged accessibility (bottom panel) H. Metaprofile plot of chromatin accessibility at 0h and 1h following IKZF1 induction at +/-1kb around sites centered at ATAC peaks with early decreased, increased or unchanged accessibility. I. Metaprofile plot of IKZF1-ERt2 binding at 0h and 1h following IKZF1 induction at sites defined in H. J. Metaprofile plot of H3K27ac levels at 0h and 1h following IKZF1 induction at sites defined in H. K. IGV browser tracks of genomic regions that show early decreased accessibility, with ATAC in blue, H3K27ac in green, IKZF1-ERt2 in red, and CHD4 in orange before (0h) and 1h following IKZF1 induction. L. Metaprofile plot of CHD4 binding at 0h and 1h following IKZF1 induction at sites defined in H.
Figure 2 IKZF1 induces rapid loss of chromatin accessibility and H3K27ac at selective sites across the genome A. Inducible IKZF1-ERt2 pre-B model, where 4-Hydroxytamoxifen (4-OHT) induces synchronous nuclear entry of IKZF1-ERt2. B. Heatmap of differentially expressed genes (padj <0.01 and log2FC>1 or <-1) over 24h nascent chromatin-associated RNA-seq timecourse following IKZF1 induction performed in duplicate, and K-means clusters of genes by behaviour into C1 Fast Repressed, C2 Slow Repressed, C3 Activated and C4 Slow Activated. C. Scaled normalized expression for K-means clusters C1 Fast Repressed, C2 Slow Repressed, C3 Activated, and C4 Slow Activated genes, with red line and grey area indicating mean and 95% confidence intervals respectively. The time for genes in each cluster to reach half-maximal repression or activation is indicated by t-half. D. Left – Total Nucleosome Free Region (NFR) ATAC peaks called by MACS2 from ATAC-seq performed in duplicate and proportion of ATAC peaks with significant differential accessibility within 2h of IKZF1 induction, decreased accessibility in blue (2h vs 0h padj<0.01, FC<0), and increased accessibility in yellow (2h vs 0h padj <0.01, FC>0). Right - Relative genomic distribution of ATAC NFR peaks at CTCF sites, Promoters, Intragenic, and Intergenic for sites with early decreased accessibility, early increased accessibility, and a subset of sites with unchanged accessibility (padj>0.05, log2FC[-0.2,0.2]), and all accessible sites. E. Homer motif analysis showing top enriched motifs at ATAC NFR regions with early decreased accessibility compared to regions with unchanged accessibility. F. Number of IKZF motif (GGAA and GGGA) at sites with early decreased accessibility, increased accessibility, or unchanged accessibility. G. IGV browser track of ATAC and IKZF1-ERt2 at 0h and 1h following IKZF1 induction at sites with early decreased accessibility (top panel) and sites with early increased or unchanged accessibility (bottom panel) H. Metaprofile plot of chromatin accessibility at 0h and 1h following IKZF1 induction at +/-1kb around sites centered at ATAC peaks with early decreased, increased or unchanged accessibility. I. Metaprofile plot of IKZF1-ERt2 binding at 0h and 1h following IKZF1 induction at sites defined in H. J. Metaprofile plot of H3K27ac levels at 0h and 1h following IKZF1 induction at sites defined in H. K. IGV browser tracks of genomic regions that show early decreased accessibility, with ATAC in blue, H3K27ac in green, IKZF1-ERt2 in red, and CHD4 in orange before (0h) and 1h following IKZF1 induction. L. Metaprofile plot of CHD4 binding at 0h and 1h following IKZF1 induction at sites defined in H.CC BY · PubMed Central
Figure 3 IKZF1 suppresses enhancer activity to repress transcription A. Heatmap and metaprofile plot of chromatin accessibility, H3K27ac, IKZF1-ERt2, and CHD4 at 0h, 30m, 1h, and 2h following IKZF1 induction +/-1kb of ATAC sites with early decreased accessibility overlapping active promoters (n=2420) or enhancers (n=6273). B. Boxplot of chromatin accessibility at active promoters and enhancers before (0h) and at early timepoints following IKZF1 induction (30m, 1h, 2h). Pairwise student’s t-test was performed for 0h vs 30m, 1h, or 2h with Bonferroni corrected p-adjusted value stated. C. Boxplot of H3K27ac at active promoters and enhancers before (0h) and at early timepoints following IKZF1 induction (30m, 1h, 2h). Pairwise student’s t-test was performed for 0h vs 30m, 1h, or 2h with Bonferroni corrected p-adjusted value stated. D. Number of accessible peaks within active enhancers in the region +/- 20kb TSS of Fast Repressed, Slow Repressed, Activated, Slow Activated, and non-differentially expressed genes. Pairwise Wilcoxon rank sum test was performed for Fast Repressed vs other gene class with Bonferroni corrected p-adjusted values stated. E. Proportion of genes that overlap with a SE within +/-50kb of the TSS, for Fast Repressed, Slow Repressed, Activated, Slow Activated, non-differentially expressed, and a randomly sampled set of genes. F. Proportion of enhancer H3K27ac peaks within +/- 20kb of TSS Fast Repressed, Slow Repressed, Activated, Slow Activated, non-differentially expressed, and randomly sampled genes that show significant (padj<0.01, FC>1.5) loss or gain of H3K27ac within 2h of IKZF1 induction. G. IGV browser of IKZF1 repressed genes at 0h and 1h after IKZF1 induction for ATAC in blue, H3K27ac in green, IKZF1-ERt2 in red, chRNA-seq and Refseq genes in navy, and boxes around promoters (P) and enhancers (E) peaks. H. Fraction of alleles with transcriptional bursting, detected using intron probes against IKZF1 repressed genes Ccnd2, Endod1, Myc, and Plekho2 at 0h and 1h after IKZF1 induction. Approximately 700 cells (x2 alleles) were analyzed for each condition. P-value was calculated using the Fisher’s Exact Test. I. Transcriptional burst size of IKZF1 repressed genes Ccnd2, Endod1, Myc, and Plekho2 at 0h and 1h after IKZF1 induction. P-value was calculated by unpaired Student’s t-test.
Figure 3 IKZF1 suppresses enhancer activity to repress transcription A. Heatmap and metaprofile plot of chromatin accessibility, H3K27ac, IKZF1-ERt2, and CHD4 at 0h, 30m, 1h, and 2h following IKZF1 induction +/-1kb of ATAC sites with early decreased accessibility overlapping active promoters (n=2420) or enhancers (n=6273). B. Boxplot of chromatin accessibility at active promoters and enhancers before (0h) and at early timepoints following IKZF1 induction (30m, 1h, 2h). Pairwise student’s t-test was performed for 0h vs 30m, 1h, or 2h with Bonferroni corrected p-adjusted value stated. C. Boxplot of H3K27ac at active promoters and enhancers before (0h) and at early timepoints following IKZF1 induction (30m, 1h, 2h). Pairwise student’s t-test was performed for 0h vs 30m, 1h, or 2h with Bonferroni corrected p-adjusted value stated. D. Number of accessible peaks within active enhancers in the region +/- 20kb TSS of Fast Repressed, Slow Repressed, Activated, Slow Activated, and non-differentially expressed genes. Pairwise Wilcoxon rank sum test was performed for Fast Repressed vs other gene class with Bonferroni corrected p-adjusted values stated. E. Proportion of genes that overlap with a SE within +/-50kb of the TSS, for Fast Repressed, Slow Repressed, Activated, Slow Activated, non-differentially expressed, and a randomly sampled set of genes. F. Proportion of enhancer H3K27ac peaks within +/- 20kb of TSS Fast Repressed, Slow Repressed, Activated, Slow Activated, non-differentially expressed, and randomly sampled genes that show significant (padj<0.01, FC>1.5) loss or gain of H3K27ac within 2h of IKZF1 induction. G. IGV browser of IKZF1 repressed genes at 0h and 1h after IKZF1 induction for ATAC in blue, H3K27ac in green, IKZF1-ERt2 in red, chRNA-seq and Refseq genes in navy, and boxes around promoters (P) and enhancers (E) peaks. H. Fraction of alleles with transcriptional bursting, detected using intron probes against IKZF1 repressed genes Ccnd2, Endod1, Myc, and Plekho2 at 0h and 1h after IKZF1 induction. Approximately 700 cells (x2 alleles) were analyzed for each condition. P-value was calculated using the Fisher’s Exact Test. I. Transcriptional burst size of IKZF1 repressed genes Ccnd2, Endod1, Myc, and Plekho2 at 0h and 1h after IKZF1 induction. P-value was calculated by unpaired Student’s t-test.CC BY · PubMed Central
Figure 4 Deregulation of fast-repressed genes in IKZF1 DN B-ALL A. GSEA analysis of early (2h) IKZF1-induced transcriptional changes in pre-B cells with gene sets for deregulated genes in IKZF1-mutated DN Ik6 B-ALL, Integrin and Cell Surface Interactions (Reactome pathway) and Cell Cycle (Reactome pathway), with NES, and number of genes indicated. GSEA FDR q-values are 0.05 for Downregulated in DN Ik6 B-ALL, 0.00 for Upregulated in DN Ik6 B-ALL, 0.04 for Integrin and Cell Surface Interactions, and 0.2 for Cell Cycle. B. GSEA enrichment plot of early (2h) IKZF1-induced transcriptional changes in pre-B cells compared with the gene set of aberrantly upregulated genes in DN Ik6 B-ALL. C. Overlap of IKZF1 Fast Repressed pre-B genes and genes aberrantly upregulated genes in DN Ik6 B-ALL. D. Super-enhancer-associated IKZF1 Fast Repressed pre-B genes that are aberrantly upregulated in IKZF1-mutated DN IK6 B-ALL, and the degree of H3K27ac change 2h after IKZF1 induction, where super-enhancers with greater than 1.5-fold increase in H3K27ac and padj <0.01 in orange, and greater than 1.5-fold decrease and padj <0.01 in H3K27ac in blue.
Figure 4 Deregulation of fast-repressed genes in IKZF1 DN B-ALL A. GSEA analysis of early (2h) IKZF1-induced transcriptional changes in pre-B cells with gene sets for deregulated genes in IKZF1-mutated DN Ik6 B-ALL, Integrin and Cell Surface Interactions (Reactome pathway) and Cell Cycle (Reactome pathway), with NES, and number of genes indicated. GSEA FDR q-values are 0.05 for Downregulated in DN Ik6 B-ALL, 0.00 for Upregulated in DN Ik6 B-ALL, 0.04 for Integrin and Cell Surface Interactions, and 0.2 for Cell Cycle. B. GSEA enrichment plot of early (2h) IKZF1-induced transcriptional changes in pre-B cells compared with the gene set of aberrantly upregulated genes in DN Ik6 B-ALL. C. Overlap of IKZF1 Fast Repressed pre-B genes and genes aberrantly upregulated genes in DN Ik6 B-ALL. D. Super-enhancer-associated IKZF1 Fast Repressed pre-B genes that are aberrantly upregulated in IKZF1-mutated DN IK6 B-ALL, and the degree of H3K27ac change 2h after IKZF1 induction, where super-enhancers with greater than 1.5-fold increase in H3K27ac and padj <0.01 in orange, and greater than 1.5-fold decrease and padj <0.01 in H3K27ac in blue.CC BY · PubMed Central
Figure 5 Conserved helical motifs in the IKZF1 IDR are required for gene repression A. Sequence alignment of mouse and human IKZF1-4 proteins, with magnified view of the α-helix-forming residues (yellow) in the internal IKZF intrinsically disordered region between ZnF4 and ZnF5. The level of conservation is shown in blue. B. AlphaFold structure of IKZF1, showing the internal disordered region between ZnF4 (blue) and ZnF5 (green), with the conserved helical motifs (Helix1 and Helix2) in yellow. C. Schematic of IKZF1 and truncation mutants, ΔN (N-terminus IDR deletion), ΔED (effector domain helical region IDR deletion), ΔPEST (proline, glutamic acid, serine, threonine-rich sequence IDR deletion), ΔC (C-terminus ZnF 5-6 deletion), DN (dominant negative Ik6). D. Immunofluorescence of B3 cells expressing HA-tagged IKZF1 WT and truncation mutants ΔN, ΔED, ΔPEST, ΔC, and DN. E. qPCR of normalized gene expression at several Fast Repressed genes before and 2h and 6h after induction with wildtype IKZF1 or mutants ΔED, ΔPEST and ΔC. Three biological replicates were performed. Primers can be found in Supplementary Methods.
Figure 5 Conserved helical motifs in the IKZF1 IDR are required for gene repression A. Sequence alignment of mouse and human IKZF1-4 proteins, with magnified view of the α-helix-forming residues (yellow) in the internal IKZF intrinsically disordered region between ZnF4 and ZnF5. The level of conservation is shown in blue. B. AlphaFold structure of IKZF1, showing the internal disordered region between ZnF4 (blue) and ZnF5 (green), with the conserved helical motifs (Helix1 and Helix2) in yellow. C. Schematic of IKZF1 and truncation mutants, ΔN (N-terminus IDR deletion), ΔED (effector domain helical region IDR deletion), ΔPEST (proline, glutamic acid, serine, threonine-rich sequence IDR deletion), ΔC (C-terminus ZnF 5-6 deletion), DN (dominant negative Ik6). D. Immunofluorescence of B3 cells expressing HA-tagged IKZF1 WT and truncation mutants ΔN, ΔED, ΔPEST, ΔC, and DN. E. qPCR of normalized gene expression at several Fast Repressed genes before and 2h and 6h after induction with wildtype IKZF1 or mutants ΔED, ΔPEST and ΔC. Three biological replicates were performed. Primers can be found in Supplementary Methods.CC BY · PubMed Central
Figure 6 Conserved helical motifs are required for NuRD-interaction and anti-proliferative function of IKZF1 A. Heatmap of relative NuRD-interaction in AP-MS of IKZF1 WT, ΔED, ΔPEST, and control cells. Four replicates were performed per condition. B. H3K27ac levels at IKZF1 Fast Repressed gene promoters and enhancers before (0h) and 2h and 6h after induction with IKZF1 WT or ΔED. ChIP-qPCR was performed in triplicate for all sites, and negative control sites are shown in Supplementary Fig. 5B. Primers can be found in Supplementary Methods. C. Western blot of human B-ALL lines Nalm6, SupB15, and BV173 transduced with equivalent levels of inducible IKZF1 or ΔED (top panel), and growth curve over seven days following induction with 4-OHT (bottom panels). SupB15 and BV173 express the IKZF1 DN Ik6 isoform. Three replicates were performed. D. AlphaMissense mean pathogenicity score by amino acid position in the IKZF1 protein. Positions of ZnF1-6 and helical motifs are indicated. E. Cell cycle analysis of pre-B cells transduced with IKZF1 WT or ΔED without induction (black) and 24h after induction with 4-OHT performed in triplicate with one representative replicate shown. The proportion of cells in G1, S, and G2/M were determined by fitting with the Watson Pragmatic Model. Three replicates were performed. F. The proportion of cells in G1, S, and G2/M in pre-B cells transduced with IKZF1 WT or ΔED without induction (black) and 24h after induction with 4-OHT performed in triplicate. Pairwise t-tests were performed between IKZF1 WT and ΔED, with the Bonferroni corrected p-adjusted value stated.
Figure 6 Conserved helical motifs are required for NuRD-interaction and anti-proliferative function of IKZF1 A. Heatmap of relative NuRD-interaction in AP-MS of IKZF1 WT, ΔED, ΔPEST, and control cells. Four replicates were performed per condition. B. H3K27ac levels at IKZF1 Fast Repressed gene promoters and enhancers before (0h) and 2h and 6h after induction with IKZF1 WT or ΔED. ChIP-qPCR was performed in triplicate for all sites, and negative control sites are shown in Supplementary Fig. 5B. Primers can be found in Supplementary Methods. C. Western blot of human B-ALL lines Nalm6, SupB15, and BV173 transduced with equivalent levels of inducible IKZF1 or ΔED (top panel), and growth curve over seven days following induction with 4-OHT (bottom panels). SupB15 and BV173 express the IKZF1 DN Ik6 isoform. Three replicates were performed. D. AlphaMissense mean pathogenicity score by amino acid position in the IKZF1 protein. Positions of ZnF1-6 and helical motifs are indicated. E. Cell cycle analysis of pre-B cells transduced with IKZF1 WT or ΔED without induction (black) and 24h after induction with 4-OHT performed in triplicate with one representative replicate shown. The proportion of cells in G1, S, and G2/M were determined by fitting with the Watson Pragmatic Model. Three replicates were performed. F. The proportion of cells in G1, S, and G2/M in pre-B cells transduced with IKZF1 WT or ΔED without induction (black) and 24h after induction with 4-OHT performed in triplicate. Pairwise t-tests were performed between IKZF1 WT and ΔED, with the Bonferroni corrected p-adjusted value stated.CC BY · PubMed Central
Figure 7 Structural basis of IKZF1 and NuRD interaction A. Protein sequence alignment of the “KRKSSMPQKF” motif present in Helix1 of IKZF family with the matching N-terminal motif found in NuRD-interacting TFs FOG1, BCL11A, SALL4. Conservation and residue properties are shown below the alignment. B. AlphaPulldown model of the interaction interface between IKZF1 Helix1 with the NuRD subunit RBBP4. Interface pTM score of 0.73. C. Close up of the KRK residues in IKZF1, FOG1 (PDB 2XU7), and BCL11A (PDB 5VTB) within the central pocket of RBBP4. D. Model of the IKZF1 Helix1 - RBBP4 interaction showing the positive KRK (residues 273-275) at the end of Helix1 positioned within the negatively charged (red) central pocket of RBBP4. The flexible loop (residues 276-281) binds along the negative charged groove between two β-propeller blades of RBBP4. E. Immunoprecipitation of HA-IKZF1 WT, ΔED, and KRK by HA-beads from nuclear extract, and immunoblot detection of NuRD subunits RBBP4 and HDAC1. F. Cell cycle analysis of pre-B cells transduced with IKZF1 WT or KRK to EDE charge-reversal mutant without induction (black) and 24h after induction with 4-OHT performed in triplicate with one representative replicate shown. The proportions of cells in G1, S, and G2/M were determined by fitting with the Watson Pragmatic Model. G. The proportion of cells in G1, S, and G2/M in pre-B cells transduced with IKZF1 WT or KRK without induction (black) and 24h after induction with 4-OHT performed in triplicate. Pairwise t tests were performed between IKZF1 WT and KRK, with the Bonferroni corrected p-adjusted value stated. H. IKZF1-NuRD mediates histone deacetyation and chromatin remodelling at target gene promoters and enhancers to mediate transcriptional repression. Mechanistically, interaction between IKZF1 and NuRD is mediated through the helical motifs in the internal IDR of IKZF1 binding to the RBBP4 subunit. I. Missense mutations in the conserved helical motif region of IKZF1, IKZF2, and IKZF3 detected in patients with hematopoietic malignancies, including pediatric B-ALL, T-ALL, Hairy cell leukemia, Hodgkin lymphoma, Diffuse large B-cell lymphoma, and Chronic myeloid leukemia. Five computational methods, Polyphen2, AlphaMissense, Fathmm, MutPred2, and Panther were used to predict the functional impact of each missense mutations - mutations in red were predicted to be pathogenic by at least 3 models, mutations in orange by 1-2 models, and mutations in black were predicted to be benign by all. Prediction scores and references can be found in Supplementary Fig. 6H and Supplementary Table 3.
Figure 7 Structural basis of IKZF1 and NuRD interaction A. Protein sequence alignment of the “KRKSSMPQKF” motif present in Helix1 of IKZF family with the matching N-terminal motif found in NuRD-interacting TFs FOG1, BCL11A, SALL4. Conservation and residue properties are shown below the alignment. B. AlphaPulldown model of the interaction interface between IKZF1 Helix1 with the NuRD subunit RBBP4. Interface pTM score of 0.73. C. Close up of the KRK residues in IKZF1, FOG1 (PDB 2XU7), and BCL11A (PDB 5VTB) within the central pocket of RBBP4. D. Model of the IKZF1 Helix1 - RBBP4 interaction showing the positive KRK (residues 273-275) at the end of Helix1 positioned within the negatively charged (red) central pocket of RBBP4. The flexible loop (residues 276-281) binds along the negative charged groove between two β-propeller blades of RBBP4. E. Immunoprecipitation of HA-IKZF1 WT, ΔED, and KRK by HA-beads from nuclear extract, and immunoblot detection of NuRD subunits RBBP4 and HDAC1. F. Cell cycle analysis of pre-B cells transduced with IKZF1 WT or KRK to EDE charge-reversal mutant without induction (black) and 24h after induction with 4-OHT performed in triplicate with one representative replicate shown. The proportions of cells in G1, S, and G2/M were determined by fitting with the Watson Pragmatic Model. G. The proportion of cells in G1, S, and G2/M in pre-B cells transduced with IKZF1 WT or KRK without induction (black) and 24h after induction with 4-OHT performed in triplicate. Pairwise t tests were performed between IKZF1 WT and KRK, with the Bonferroni corrected p-adjusted value stated. H. IKZF1-NuRD mediates histone deacetyation and chromatin remodelling at target gene promoters and enhancers to mediate transcriptional repression. Mechanistically, interaction between IKZF1 and NuRD is mediated through the helical motifs in the internal IDR of IKZF1 binding to the RBBP4 subunit. I. Missense mutations in the conserved helical motif region of IKZF1, IKZF2, and IKZF3 detected in patients with hematopoietic malignancies, including pediatric B-ALL, T-ALL, Hairy cell leukemia, Hodgkin lymphoma, Diffuse large B-cell lymphoma, and Chronic myeloid leukemia. Five computational methods, Polyphen2, AlphaMissense, Fathmm, MutPred2, and Panther were used to predict the functional impact of each missense mutations - mutations in red were predicted to be pathogenic by at least 3 models, mutations in orange by 1-2 models, and mutations in black were predicted to be benign by all. Prediction scores and references can be found in Supplementary Fig. 6H and Supplementary Table 3.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Cited by

See all 15

Metadata

Authors
Zhang, T., Wang, Y.-F., Montoya, A., Patrascan, I., Nebioglu, N., Pallikonda, H. A., Georgieva, R., King, J. W. D., Kramer, H. B., Shliaha, P. V., Rueda, D. S., & Merkenschlager, M.
Affiliations
Imperial College London (GB)
Corresponding author
  • Zhang, Tianyi
  • Rueda, David S.
  • Merkenschlager, Matthias
Venue
Blood
Published
2025-01-23
Volume
145
Issue
4
Pages
422-437
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W4403629186
Cited by
14
References
80
Citations by year
2026: 5 · 2025: 9
FWCI
1.91
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, cc-by)
  • PubMed Central (acceptedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Yale University
  • Wellcome Trust (215933, 215933/Z/19/Z, 099276/Z/12/Z, 099276)
  • Leverhulme Trust (RPG-2016-214)
  • University of Leicester
  • Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
IKZF1, intrinsically disordered regions, helical motifs, RBBP4, transcriptional repression, chromatin accessibility, H3K27 acetylation, enhancers, transcriptional bursts, B-cell acute lymphoblastic leukemia, pre-B cells, FOG-1, BCL11A, SALL4
MeSH terms
Animals, Chromatin, Humans, Protein Binding, Transcription, Genetic, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Conserved Sequence, Amino Acid Motifs, Mice, Ikaros Transcription Factor, Precursor Cells, B-Lymphoid, Mi-2 Nucleosome Remodeling and Deacetylase Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression. https://app.cochat.ai/papers/10.1182/blood.2024024787
The paper
Zhang, T., Wang, Y.-F., Montoya, A., Patrascan, I., Nebioglu, N., Pallikonda, H. A., Georgieva, R., King, J. W. D., Kramer, H. B., Shliaha, P. V., Rueda, D. S., & Merkenschlager, M. (2025). Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression. Blood. https://doi.org/10.1182/blood.2024024787

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.